Published in
Springer, Cancer Immunology, Immunotherapy, 8(67), p. 1305-1315, 2018
DOI: 10.1007/s00262-018-2190-4
Links
Tools
Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma
Journal article published in 2018 by
Zachary J. Brown,
Su Jong Yu,
Bernd Heinrich,
Chi Ma,
Qiong Fu,
Milan Sandhu,
David Agdashian,
Qianfei Zhang,
Firouzeh Korangy,
Tim F. Greten 
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 